May 7th 2024
The FDA is set to have a decision regarding the subcutaneous nivolumab formulation on or by February 28, 2025.
Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy
View More
How the Experts Treat NMIBC During a BCG Shortage—Integrating Recent Approvals and Investigational Therapies
View More
Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies
View More
Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?
View More
Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer
View More
Medical Crossfire®: How Will Emerging Data Inform Treatment Planning for Patients With Prostate Cancer in the Community?
View More
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
New hope for treating deep renal tumors?
March 1st 2015If further work with irreversible electroporation refines its capacity for discrete tissue ablation deep within the kidney and adjacent to large blood vessels, and especially if larger tumors can be addressed, then this would be a major step forward in the minimally invasive treatment of localized renal cancer.
Nonthermal technique promising for small renal tumors
March 1st 2015Percutaneous irreversible electroporation is showing promise as a novel minimally invasive approach for treating small renal tumors, according to the experience of urologists at the University of Texas Southwestern Medical Center, Dallas.
USC urologists take robot to next level in thrombectomy - VIDEO
January 6th 2015Urologists at the University of Southern California’s Institute of Urology in Los Angeles are taking robotic kidney surgery to a new level. Inderbir S. Gill, MD, MCh, executive director of the USC Institute of Urology, has pioneered the use of the robot in patients with complex (level III) inferior vena cava thrombi.
January 2015 New Products: Ultrasound system offers multiple features, high-resolution images
January 2nd 2015New products and services from Samsung Electronics America, Syneron Medical, American Medical Systems, New Star, Buffalo Filter, Cook Medical, Endo International, Trimel BioPharma Metamark, and the National Comprehensive Cancer Network.
January 2015 Product Preview: FDA committee recommends approval of complicated UTI agent
December 31st 2014Drugs and devices in the pipeline from Actavis, Genomic Health, Lipella Pharmaceuticals, Polaris Group, Innocrin Pharmaceuticals, OncoGenex Pharmaceuticals, Heat Biologics, Repros Therapeutics, and Sophiris Bio.
Robot linked with improved kidney Ca care
December 15th 2014Kidney cancer patients were more likely to undergo partial nephrectomy when treated in hospitals that were early adopters of robotic surgery, according to a recent report that one leading expert calls “some of the best evidence to date of a favorable impact of surgical robots in urologic care.”
Smoking raises risk of second smoking-related cancer
November 17th 2014Survivors of bladder, kidney, and two other forms of cancer who smoked 20 or more cigarettes a day prior to their cancer diagnoses have an up to fivefold higher risk of developing a second smoking-associated cancer compared to survivors of the same cancers who never smoked.
Urology Product Preview: Testosterone agent meets efficacy endpoint in phase III studies
August 11th 2014Drugs and devices in the pipeline form Clarus Therapeutics, Nymox Pharmaceutical, Bioniche Life Sciences, Repros Therapeutics, BioLight Life Sciences Investments/Micromedic Technologies, Cubist Pharmaceuticals, Takeda Pharmaceutical, H. Lundbeck A/S, Transplant Genomics, Orion, Bayer, and Roche.
Use of robotic RN rising, despite unclear advantages
July 2nd 2014The use of robot-assisted radical nephrectomy increased by 6% over a recent 3-year period, and high-volume robotic centers for partial nephrectomy were found more likely to perform robotic radical nephrectomy despite its increased cost and similar complications to laparoscopic radical nephrectomy, according to a recent study.